by Ed Susman: For More Info, Go Here…
It’s a lot to swallow but the pilot study shows benefit for hepatic encephalopathy.
Patients who swallowed fecal microbiota capsules had fewer attacks of recurrent hepatic encephalopathy, a devastating complication of liver cirrhosis, in a placebo-controlled pilot trial reported here.
During the study’s 6-month course and follow-up, 11 serious adverse events – hospitalization or death – were seen in the 10 patients assigned to placebo compared to one in the 10-patient intervention group (P=0.02), reported Jasmohan Bajaj, MD, MBBS, of Virginia Commonwealth University in Richmond. None of the adverse events were associated with study medications, he said.